Role of Syndecan-4 in the Inhibition of Articular Cartilage Degeneration in Osteoarthritis

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2023 Aug 26

PMID 37626753

Authors

Yoshio Hattori

Masahiro Hasegawa

Takahiro Iino

Kyoko Imanaka-Yoshida

Akihiro Sudo

Affiliations

Soon will be listed here.

Abstract

Despite its widespread existence, there are relatively few drugs that can inhibit the progression of osteoarthritis (OA). Syndecan-4 (SDC4) is a transmembrane heparan sulfate proteoglycan that modulates cellular interactions with the extracellular matrix. Upregulated SDC4 expression in articular cartilage chondrocytes correlates with OA progression. In the present study, we treated osteoarthritic cartilage with SDC4 to elucidate its role in the disease's pathology. In this in vitro study, we used real-time polymerase chain reaction (PCR) to investigate the effects of SDC4 on anabolic and catabolic factors in cultured chondrocytes. In the in vivo study, we investigated the effect of intra-articular injection of SDC4 into the knee joints of an OA mouse model. In vitro, SDC4 upregulated the expression of tissue inhibitor of metalloproteinase (TIMP)-3 and downregulated the expression of matrix metalloproteinase (MMP)-13 and disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-5 in chondrocytes. Injection of SDC4 into the knee joints of OA model mice prevented articular cartilage degeneration 6 and 8 weeks postoperatively. Immunohistochemical analysis 8 weeks after SDC4 injection into the knee joint revealed decreased ADAMTS-5 expression and increased TIMP-3 expression. The results of this study suggest that the treatment of osteoarthritic articular cartilage with SDC4 inhibits cartilage degeneration.

Citing Articles

Syndecans, Exostosins and Sulfotransferases as Potential Synovial Inflammation Moderators in Patients with Hip Osteoarthritis.

Rosin M, Kelam N, Juric I, Racetin A, Ogorevc M, Corre B Int J Mol Sci. 2024; 25(8).

PMID: 38674142 PMC: 11049902. DOI: 10.3390/ijms25084557.

References

Moreau M, Rialland P, Pelletier J, Martel-Pelletier J, Lajeunesse D, Boileau C . Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model. Arthritis Res Ther. 2011; 13(3):R98. PMC: 3218913. DOI: 10.1186/ar3373. View

Lim N, Kashiwagi M, Visse R, Jones J, Enghild J, Brew K . Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications. Biochem J. 2010; 431(1):113-22. PMC: 3003256. DOI: 10.1042/BJ20100725. View

Nikmanesh M, Cancel L, Shi Z, Tarbell J . Heparan sulfate proteoglycan, integrin, and syndecan-4 are mechanosensors mediating cyclic strain-modulated endothelial gene expression in mouse embryonic stem cell-derived endothelial cells. Biotechnol Bioeng. 2019; 116(10):2730-2741. DOI: 10.1002/bit.27104. View

Rhodes L, Grainger A, Keenan A, Thomas C, Emery P, Conaghan P . The validation of simple scoring methods for evaluating compartment-specific synovitis detected by MRI in knee osteoarthritis. Rheumatology (Oxford). 2005; 44(12):1569-73. DOI: 10.1093/rheumatology/kei094. View

Fitzgerald M, Wang Z, Park P, Murphy G, Bernfield M . Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol. 2000; 148(4):811-24. PMC: 2169376. DOI: 10.1083/jcb.148.4.811. View

Matsui Y, Hasegawa M, Iino T, Imanaka-Yoshida K, Yoshida T, Sudo A . Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models. Cartilage. 2017; 9(1):80-88. PMC: 5724670. DOI: 10.1177/1947603516681134. View

Clockaerts S, Bastiaansen-Jenniskens Y, Runhaar J, van Osch G, Van Offel J, Verhaar J . The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review. Osteoarthritis Cartilage. 2010; 18(7):876-82. DOI: 10.1016/j.joca.2010.03.014. View

Bruyere O, Honvo G, Veronese N, Arden N, Branco J, Curtis E . An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019; 49(3):337-350. DOI: 10.1016/j.semarthrit.2019.04.008. View

Krenn V, Morawietz L, Burmester G, Kinne R, Mueller-Ladner U, Muller B . Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology. 2006; 49(4):358-64. DOI: 10.1111/j.1365-2559.2006.02508.x. View

10.

Kurtz S, Lau E, Ong K, Zhao K, Kelly M, Bozic K . Future young patient demand for primary and revision joint replacement: national projections from 2010 to 2030. Clin Orthop Relat Res. 2009; 467(10):2606-12. PMC: 2745453. DOI: 10.1007/s11999-009-0834-6. View

11.

Wilcox-Adelman S, Denhez F, Goetinck P . Syndecan-4 modulates focal adhesion kinase phosphorylation. J Biol Chem. 2002; 277(36):32970-7. DOI: 10.1074/jbc.M201283200. View

12.

Saoncella S, Echtermeyer F, Denhez F, Nowlen J, Mosher D, Robinson S . Syndecan-4 signals cooperatively with integrins in a Rho-dependent manner in the assembly of focal adhesions and actin stress fibers. Proc Natl Acad Sci U S A. 1999; 96(6):2805-10. PMC: 15850. DOI: 10.1073/pnas.96.6.2805. View

13.

Bernfield M, Gotte M, Park P, Reizes O, Fitzgerald M, Lincecum J . Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem. 2000; 68:729-77. DOI: 10.1146/annurev.biochem.68.1.729. View

14.

Binch A, Shapiro I, Risbud M . Syndecan-4 in intervertebral disc and cartilage: Saint or synner?. Matrix Biol. 2016; 52-54:355-362. PMC: 4875798. DOI: 10.1016/j.matbio.2016.01.005. View

15.

Kato M, Wang H, Kainulainen V, Fitzgerald M, Ledbetter S, Ornitz D . Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nat Med. 1998; 4(6):691-7. DOI: 10.1038/nm0698-691. View

16.

Lim S, Longley R, Couchman J, Woods A . Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J Biol Chem. 2003; 278(16):13795-802. DOI: 10.1074/jbc.M208300200. View

17.

Ayral X, Pickering E, Woodworth T, Mackillop N, Dougados M . Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis -- results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage. 2005; 13(5):361-7. DOI: 10.1016/j.joca.2005.01.005. View

18.

Kisand K, Tamm A, Lintrop M, Tamm A . New insights into the natural course of knee osteoarthritis: early regulation of cytokines and growth factors, with emphasis on sex-dependent angiogenesis and tissue remodeling. A pilot study. Osteoarthritis Cartilage. 2018; 26(8):1045-1054. DOI: 10.1016/j.joca.2018.05.009. View

19.

Cornelison D, Filla M, Stanley H, Rapraeger A, Olwin B . Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol. 2002; 239(1):79-94. DOI: 10.1006/dbio.2001.0416. View

20.

Tkachenko E, Rhodes J, Simons M . Syndecans: new kids on the signaling block. Circ Res. 2005; 96(5):488-500. DOI: 10.1161/01.RES.0000159708.71142.c8. View